Interval breast cancers - symptomatic cancers diagnosed within a period between regular screening mammography exams - tend to have poorer outcomes due to their more aggressive biology and rapid growth.
Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an AI principal investigator and seasoned scientists.
The study was published in the journal npj Digital Medicine.